Clinical Trial Update: Clinical Study of Allogeneic Vγ9Vδ2 T Cells in the Treatment of Brain Malignant Glioma [EARLY_Phase 1]

View source ↗

Summary

This entry describes an early-stage Phase 1 clinical study evaluating allogeneic Vγ9Vδ2 T cells for malignant gliomas, including glioblastoma, DIPG, and medullo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Intrinsic Pontine Glioma
• Glioblastoma
• Medulloblastoma

Drugs mentioned

• Allogeneic Vγ9Vδ2 T cells (V gamma 9 V delta 2 T cells)

Snippet

Sponsor: Beijing Tiantan Hospital | Conditions: GBM, DIPG Brain Tumor | EARLY_Phase 1 | Status: NOT_YET_RECRUITING